Bone and cartilage malignant tumor(chondrosarcomafrom TissueArray |
|
T264a | each: 78.00 EUR | |
Description: Bone and cartilage malignant tumor(chondrosarcoma, osteosarcoma, Ewing's sarcoma) tissue array, including TNM and clinical stage, 6 cases/24 cores, replacing T264 |
|
7 types of common malignant tumor tissuesfrom TissueArray |
|
CTRL143 | each: 54.00 EUR | |
Description: 7 types of common malignant tumor tissues, including pathology grade, TNM and clinical stage, 7 cases/14 cores |
|
Skin malignant tumor tissue arrayfrom TissueArray |
|
BC21014 | each: 270.00 EUR | |
Description: Skin malignant tumor tissue array, 78 cases/78 cores, replacing BC21011 |
|
Liver Tissue Slide (Malignant tumor)from ProSci |
|
10-220-10um | 10 um: 241.80 EUR | |
Liver Tissue Slide (Malignant tumor)from ProSci |
|
10-220-4um | 4 um: 216.60 EUR | |
Ovary Tissue Slide (Malignant Tumor)from ProSci |
|
11-206-10um | 10 um: 241.80 EUR | |
Ovary Tissue Slide (Malignant Tumor)from ProSci |
|
11-206-4um | 4 um: 216.60 EUR | |
Stomach Tissue Slide (Malignant Tumor)from ProSci |
|
10-807-10um | 10 um: 241.80 EUR | |
Stomach Tissue Slide (Malignant Tumor)from ProSci |
|
10-807-4um | 4 um: 216.60 EUR | |
Stomach Tissue Slide (Malignant Tumor)from ProSci |
|
RF10002-05-10um | 10 um: 241.80 EUR | |
Stomach Tissue Slide (Malignant Tumor)from ProSci |
|
RF10002-05-4um | 4 um: 216.60 EUR | |
Soft tissue malignant tumor tissue arrayfrom TissueArray |
|
T244 | each: 48.00 EUR | |
Description: Soft tissue malignant tumor tissue array, including TNM and clinical stage, 6 cases/24 cores |
|
Mesentery primarily malignant tumor tissue arrayfrom TissueArray |
|
MY801 | each: 474.00 EUR | |
Description: Mesentery primarily malignant tumor tissue array, 40 cases/80 cores |
|
Human Liver Slide (Malignant Tumor) (5 slides/pk)from Alpha Diagnostics |
|
HTS-10220 | 1 pk: 343.20 EUR | |
Oral cavity benign and malignant tumor(hemangiomafrom TissueArray |
|
OR803 | each: 306.00 EUR | |
Description: Oral cavity benign and malignant tumor(hemangioma, granulomatous type capillary hemangioma, capillary hemangioma, basal cell papilloma, lymphangioma, odontogenic myxoma, odontogenic fibroma, calcifying epithelial odontogenic tumor, basal cell adenoma, mixed tumor, multiform adenoma, adenolymphoma, ossifying fibroma, neurofibroma, lipoma, basal cell carcinoma, verrucous carcinoma, adenocarcinoma, adenoid cystic carcinoma, mucoepidermoid carcinoma, follicular lymphoma, Hodgkin's disease, fibrohistiocytoma, fibrosarcoma, myxoid chondrosarcoma, Ewing's sarcoma, ameloblastoma, squamous cell carcinoma, osteosarcoma) tissue array, including TNM, clinical stage and pathology grade, 40 cases/ 80 cores |
|
Human CD34+ Bone Marrow Cellsfrom AcceGen |
|
ABC-TC3558 | 1 vial: Ask for price | |
Description: Human CD34+ bone marrow cells are derived from whole bone marrow and purified using magnetic cell separation. Human CD34+ bone marrow cells may be from a single or multiple donors and are 95% pure populations as confirmed by FACS analysis. |
|
Bone tumor and bone marrow tissue arrayfrom TissueArray |
|
BM483d | each: 474.00 EUR | |
Description: Bone tumor and bone marrow tissue array, containing plasma cell myeloma (MM), primitive neuroectodermal tumor(PNET), Ewing's sarcoma and diffuse large B-cell lymphoma,24 cases/48 cores (core size 1.5mm), replacing BM483c |
|
Bladder Tissue Slide (Malignant epithelial tumor)from ProSci |
|
12-610-10um | 10 um: 241.80 EUR | |
Bladder Tissue Slide (Malignant epithelial tumor)from ProSci |
|
12-610-4um | 4 um: 216.60 EUR | |
Human Ovary Tissue Slide (Malignant tumor) (5 slides/pk)from Alpha Diagnostics |
|
HTS-11206 | 1 pk: 343.20 EUR | |
Human CD 34+ Bone Marrow Cellsfrom AcceGen |
|
ABC-TC3555 | 1 vial: Ask for price | |
Description: Human CD34+ bone marrow cells are derived from whole bone marrow and purified using magnetic cell separation. Human CD34+ bone marrow cells are from a single donor and are 95% pure populations as confirmed by FACS analysis. |
|
Human Bone Marrow CD34+ Cellsfrom AcceGen |
|
ABC-TC3117 | 1 vial: Ask for price | |
Description: Bone Marrow-CD34+ stem/progenitor cells are positively isolated using a direct immunomagnetic CD34 MicroBead labeling system. |
|
Human Bone Marrow CD34+ Cellsfrom Creative Bioarray |
|
CSC-7685W | One Frozen vial: Ask for price | |
Human Bone Marrow CD133+ Cellsfrom AcceGen |
|
ABC-TC3115 | 1 vial: Ask for price | |
Description: Bone Marrow CD133+ Progenitor cells are positively isolated using a direct immunomagnetic CD133 MicroBead labeling system. The majority of CD133+ cells express the CD34 marker as well. |
|
Human CD34+ Bone Marrow Cells, Pooledfrom AcceGen |
|
ABC-TC3314 | 1 vial: Ask for price | |
Description: Human CD34+ bone marrow cells are derived from whole bone marrow and purified using magnetic cell separation. Human CD34+ bone marrow cells may be from a single or multiple donors and are 95% pure populations as confirmed by FACS analysis. These cell types enable researchers to produce various cell types using standard published protocols. In addition, CD34+ bone marrow cells can be used for various studies on hematopoiesis, differentiation, angiogenesis, colony formation, and surface marker expression. Presently, they are one of the most widely used cell types for various therapeutic applications. Development period: Prenata |
|
Rat Bone Marrow Mononuclear Cellsfrom AcceGen |
|
ABC-TC4087 | 1 vial: Ask for price | |
Description: Rat bone marrow is procured from the rat femurs and humeri. The Mononuclear Cells are subsequently enriched by density gradient separation. |
|
Human Bone Marrow Mononuclear Cellsfrom AcceGen |
|
ABC-TC3516 | 1 vial: Ask for price | |
Description: Human bone marrow mononuclear cells are isolated via density gradient centrifugation, from whole bone marrow of a single donor. This heterogeneous cell population allows researchers to isolate various cell types of the immune system. Human bone marrow mononuclear cells consist of multiple types of cells including lymphocytes, monocytes, mesenchymal stem cells and hematopoietic progenitor cells, especially rich in hematopoeitic stem cells. CD34 is a marker of human HSC. Human bone marrow mononuclear cells enable researchers to investigate the immune system, stem cells, and regenerative medicine. In addition, they may be used for developmental studies. |
|
Mouse Bone Marrow Mononuclear Cellsfrom AcceGen |
|
ABC-TC3917 | 1 vial: Ask for price | |
Description: Mouse bone marrow is procured from the mouse femurs and humeri. The mononuclear cells are enriched by density gradient separation. |
|
Canine Bone Marrow Mononuclear Cellsfrom AcceGen |
|
ABC-SC0134T | 1 vial: Ask for price | |
Description: Canines are often used as a non-rodent model for studying the efficacy and safety of newly developed drugs and chemicals. This is mostly due to the similarities in their anatomical morphology and physiology compared to humans.Bone Marrow Mononuclear Cells (BMMCs) are a heterogenous mixture of cells isolated from bone marrow and is especially rich in hematopoeitic stem cells. BMMCs consist of several types of cells including lymphocytes, monocytes, mesenchymal stem cells and hematopoietic progenitor cells and are isolated from bone marrow aspirate via density gradient centrifugation.Used for a variety of applications, BMMCs are frequently utilized in drug discovery/development, assay validation/development, cell therapy research, and other immunology applications.Features and BenefitsIsolated from bone marrow aspirate collected from a variety of anticoagulantsAvailable in custom formats and aliquot sizesRigorous QC ensures consistent, reliable cell lots |
|
Head & Neck Tumor Tissue Array - 48 cases of inflammatory, benign and malignant tumor tissues of the neck, oranasopharynfrom Biochain |
|
Z7020051 | 5 slides: 1657.20 EUR | |
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool. |
|
Multiple Tumor Tissue Array - Duplicated 48 cases of benign and malignant tumors of the nervous systemfrom Biochain |
|
Z7020084 | 5 slides: 1657.20 EUR | |
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool. |
|
Pediatric malignant tumor tissue array with normal tissue as controlfrom TissueArray |
|
PC701 | each: 306.00 EUR | |
Description: Pediatric malignant tumor tissue array with normal tissue as control, 70 cases/ 70 cores |
|
Human Bone Marrow CD34+ Stem Cellsfrom 101Bio |
|
BMCD34-C0.5M | 0.5 million: 780.00 EUR | |
Human Bone Marrow CD34+ Stem Cellsfrom 101Bio |
|
BMCD34-C1M | 1 million: 1320.00 EUR | |
Human Bone Marrow CD34+ Stem Cellsfrom 101Bio |
|
BMCD34-C5M | 5 million: 6360.00 EUR | |
Human Bone Marrow CD34+ Stem Cellsfrom 101Bio |
|
BMCD34-deplete | 100 million: 426.00 EUR | |
Human Bone Marrow CD34+ Stem Cellsfrom 101Bio |
|
BMCD34-F0.5M | 0.5 million: 838.80 EUR | |
Human Bone Marrow CD34+ Stem Cellsfrom 101Bio |
|
BMCD34-F5M | 5 million: 6960.00 EUR | |
Paraffin Tissue Section - Human Skin Tumor: Malignant Melanomafrom Biochain |
|
T2235218-3 | 5 slides: 262.00 EUR | |
Human Bladder Slide (Malignant epithelial tumor) (5 slides/pk)from Alpha Diagnostics |
|
HTS-12610 | 1 pk: 343.20 EUR | |
Bone marrow tumor and normal tissue arrayfrom TissueArray |
|
T293b | each: 78.00 EUR | |
Description: Bone marrow tumor and normal tissue array, including TNM, 6 cases/24 cores, replacing T293 |
|
Human Bone Marrow CD33+ Myeloid Cellsfrom AcceGen |
|
ABC-TC3116 | 1 vial: Ask for price | |
Description: Bone Marrow-CD33+ myeloid cells are positively isolated from Bone Marrow-Mononuclear Cells using a direct immunomagnetic CD33 MicroBead labeling system. |
|
Rat Bone Marrow Mesenchymal Stem Cellsfrom Elabscience Biotech |
|
CP-R131 | 5×105 cells/vial: 580.00 EUR | |
Description: Rat |
|
Paraffin Tissue Section - Human Pelvic Tumor: Malignant Mesotheliomafrom Biochain |
|
T2235193-2 | 5 slides: 262.00 EUR | |
Mouse Bone Marrow Mesenchymal Stem Cellsfrom AcceGen |
|
ABC-TC3916 | 1 vial: Ask for price | |
Description: Mouse bone marrow mesenchymal stem cells, 6-week ICR mouse |
|
Mouse Bone Marrow Mesenchymal Stem Cellsfrom Elabscience Biotech |
|
CP-M131 | 5×105 cells/vial: 580.00 EUR | |
Description: Mouse |
|
Human Bone Marrow Mesenchymal Stem Cellsfrom Cyagen |
|
HUXMA-01001 | 1*10^6/vial: 1030.00 EUR | |
Human Mesenchymal Stem cells Bone Marrowfrom Alphabioregen |
|
ALHE31 | 1ml frozen Vial: 620.00 EUR | |
Canine Bone Marrow Mesenchymal Stem Cellsfrom Cyagen |
|
CAXMX-01001 | 1*10^6/vial: 999.00 EUR | |
Human Bone Marrow Mononuclear Cells (BMMCs)from 101Bio |
|
BMMN-C10M | 10 million: 358.80 EUR | |
Human Bone Marrow Mononuclear Cells (BMMCs)from 101Bio |
|
BMMN-C20M | 20 million: 478.80 EUR | |
Human Bone Marrow Mononuclear Cells (BMMCs)from 101Bio |
|
BMMN-C50M | 50 million: 936.00 EUR | |
Human Bone Marrow Mononuclear Cells (BMMCs)from 101Bio |
|
BMMN-C5M | 5 million: 190.80 EUR | |
Human Bone Marrow Mononuclear Cells (BMMCs)from 101Bio |
|
BMMN-F100M | 100 million: 1560.00 EUR | |
Human Bone Marrow Mononuclear Cells (BMMCs)from 101Bio |
|
BMMN-F200M | 200 million: 3000.00 EUR | |
Human Bone Marrow Mononuclear Cells (BMMCs)from 101Bio |
|
BMMN-F50M | 50 million: 828.00 EUR | |
Rabbit Bone Marrow Mesenchymal Stem Cellsfrom AcceGen |
|
ABC-TC4058 | 1 vial: Ask for price | |
Description: Rabbit bone marrow mesenchymal stem cells, 5-week rabbit |
|
Human Bone Marrow Mononuclear Cells, Fetalfrom AcceGen |
|
ABC-TC3122 | 1 vial: Ask for price | |
Description: Bone Marrow-Mononuclear Cells are isolated by diluting bone marrow with phosphatebuffered saline and using density gradient separation techniques. After centrifugation, the Mononuclear Cells layer is collected. Mononuclear Cells can be processed further to isolate various subpopulations. |
|
Rabbit Bone Marrow Mesenchymal Stem Cellsfrom Elabscience Biotech |
|
CP-Rb007 | 5×105 cells/vial: 610.00 EUR | |
Description: Rabbit |
|
Rabbit Bone Marrow Mesenchymal Stem Cellsfrom Cyagen |
|
RBXMX-01001 | 1*10^6/vial: 649.00 EUR | |
Paraffin Tissue Section - Human Abdominal Tumor: Malignant Mesotheliomafrom Biochain |
|
T2235001-6 | 5 slides: 262.00 EUR | |
Mesenchymal Stem Cells - Bone Marrow Derivedfrom Neuromics |
|
SC00BM1 | 500,000 cells: 1086.00 EUR | |
Monkey Bone Marrow Macrophages (Frozen Cells)from AcceGen |
|
ABC-TC5534 | 1 vial: Ask for price | |
Description: Monkey Bone Marrow Macrophages are derived from the tibias or femurs of Cynomolgus Monkey. Cells at passage 0 are cryo-preserved in vials. Each vial contains 6x106 cells and is delivered frozen. Cells are negative for bacteria, yeast, fungi, and mycoplasma and tested for expression of markers using antibody, CD11b by flow cytometry. Cells can be expanded on a multiwell culture plate ready for experiments under the cell culture conditions specified by Gentaur. Repeated freezing and thawing of cells is not recommended. |
|
Human Primary Bone Marrow Mononuclear Cellsfrom ABM |
|
T4022 | 5x10^5 cells / 1.0 ml: Ask for price | |
Human CD 133 Positive (CD133+) Bone Marrow Cellsfrom AcceGen |
|
ABC-TC3552 | 1 vial: Ask for price | |
Description: CD133+ human bone marrow cells are derived from bone marrow and purified using magnetic cell separation. These cells may be from a single or multiple donors depending upon your experimental needs. |
|
Lethal(3)malignant Brain Tumor-Like Protein 1 (L3MBTL1) Antibodyfrom Abbexa |
|
20-abx320570 | [ 100 ul: Ask for price ] [ 50 ul: Ask for price ] | |
Lethal(3)malignant Brain Tumor-Like Protein 2 (L3MBTL2) Antibodyfrom Abbexa |
|
20-abx301111 | [ 100 ug: Ask for price ] [ 1 mg: Ask for price ] [ 200 ug: Ask for price ] [ 20 ug: Ask for price ] [ 50 ug: Ask for price ] | |
Lethal(3)malignant Brain Tumor-Like Protein 4 (L3MBTL4) Antibodyfrom Abbexa |
|
20-abx301539 | [ 100 ug: Ask for price ] [ 1 mg: Ask for price ] [ 200 ug: Ask for price ] [ 20 ug: Ask for price ] [ 50 ug: Ask for price ] | |
Lethal(3)malignant Brain Tumor-Like Protein 3 (L3MBTL3) Antibodyfrom Abbexa |
|
abx034719-400ul | 400 ul: 627.60 EUR | |
Lethal(3)malignant Brain Tumor-Like Protein 3 (L3MBTL3) Antibodyfrom Abbexa |
|
abx034719-80l | 80 µl: 343.20 EUR | |
Lethal(3)malignant Brain Tumor-Like Protein 2 (L3MBTL2) Antibodyfrom Abbexa |
|
20-abx126073 | [ 100 ul: Ask for price ] [ 200 ul: Ask for price ] [ 20 ul: Ask for price ] [ 50 ul: Ask for price ] | |
Lethal(3)malignant Brain Tumor-Like Protein 3 (L3MBTL3) Antibodyfrom Abbexa |
|
20-abx141391 | [ 100 ul: Ask for price ] [ 200 ul: Ask for price ] [ 50 ul: Ask for price ] | |
Lethal(3)malignant Brain Tumor-Like Protein 2 (L3MBTL2) Antibodyfrom Abbexa |
|
abx145642-100ug | 100 ug: 469.20 EUR | |
Lethal(3)malignant Brain Tumor-Like Protein 4 (L3MBTL4) Antibodyfrom Abbexa |
|
abx145643-100ug | 100 ug: 469.20 EUR | |
Lethal(3)malignant Brain Tumor-Like Protein 1 (L3MBTL1) Antibodyfrom Abbexa |
|
20-abx005360 | [ 100 ul: Ask for price ] [ 200 ul: Ask for price ] [ 20 ul: Ask for price ] [ 50 ul: Ask for price ] | |
Lethal(3)malignant Brain Tumor-Like Protein 3 (L3MBTL3) Antibodyfrom Abbexa |
|
20-abx005496 | [ 100 ul: Ask for price ] [ 200 ul: Ask for price ] [ 20 ul: Ask for price ] [ 50 ul: Ask for price ] | |
Lethal(3)malignant Brain Tumor-Like Protein 1 (L3MBTL1) Antibodyfrom Abbexa |
|
abx005360-100l | 100 µl: 175.00 EUR | |
Lethal(3)malignant Brain Tumor-Like Protein 1 (L3MBTL1) Antibodyfrom Abbexa |
|
abx005360-500l | 500 µl: 275.00 EUR | |
Lethal(3)malignant Brain Tumor-Like Protein 3 (L3MBTL3) Antibodyfrom Abbexa |
|
abx005496-100l | 100 µl: 175.00 EUR | |
Lethal(3)malignant Brain Tumor-Like Protein 2 (L3MBTL2) Antibodyfrom Abbexa |
|
abx301111-100g | 100 µg: 362.50 EUR | |
Lethal(3)malignant Brain Tumor-Like Protein 2 (L3MBTL2) Antibodyfrom Abbexa |
|
abx301111-20g | 20 µg: 162.50 EUR | |
Lethal(3)malignant Brain Tumor-Like Protein 2 (L3MBTL2) Antibodyfrom Abbexa |
|
abx301111-50g | 50 µg: 250.00 EUR | |
Lethal(3)malignant Brain Tumor-Like Protein 4 (L3MBTL4) Antibodyfrom Abbexa |
|
abx301539-100g | 100 µg: 362.50 EUR | |
Lethal(3)malignant Brain Tumor-Like Protein 4 (L3MBTL4) Antibodyfrom Abbexa |
|
abx301539-20g | 20 µg: 162.50 EUR | |
Lethal(3)malignant Brain Tumor-Like Protein 4 (L3MBTL4) Antibodyfrom Abbexa |
|
abx301539-50g | 50 µg: 250.00 EUR | |
Lethal(3)malignant Brain Tumor-Like Protein 2 (L3MBTL2) Antibodyfrom Abbexa |
|
abx126073-100l | 100 µl: 175.00 EUR | |
Lethal(3)malignant Brain Tumor-Like Protein 2 (L3MBTL2) Antibodyfrom Abbexa |
|
abx126073-1ml | 1 ml: 400.00 EUR | |
Lethal(3)malignant Brain Tumor-Like Protein 2 (L3MBTL2) Antibodyfrom Abbexa |
|
abx126073-200l | 200 µl: 275.00 EUR |